<DOC>
	<DOCNO>NCT01349504</DOCNO>
	<brief_summary>Hypothesis : Mesalamine commonly use induce maintain remission patient Inflammatory Bowel Disease ( IBD ) . Behavioral psycho-social barrier mesalamine adherence exist patient IBD . These factor identify use qualitative test order develop validate instrument measure `` adherence profile '' individual patient , design appropriate behavioral intervention reduce non-adherence . Objectives : To test novel interview instrument determine medication adherence profile patient IBD prescribe mesalamine correlate objective measure adherence</brief_summary>
	<brief_title>Adherence Mesalamine Profile Patients With Inflammatory Bowel Disease</brief_title>
	<detailed_description>Specific Aims : 1 . To test novel interview instrument classify patient `` adherence profile '' 2 . To validate instrument quantitative score mesalamine adherence objective testing . Study Design Rationale : Qualitative research design prospective validation</detailed_description>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Adult patient ( age &gt; 18 ) Diagnosis IBD ( confirm endoscopy histology ) &gt; 3 month In clinical remission ( base Simple Colitis Activity Index score &lt; 2.5 ) On mesalamine compound maintenance remission Stable mesalamine dose 1 month Not receive primary GI care BIDMC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>